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Strengths and limitations of this study
 Ź A Markov cohort model was developed based on 
currently available evidence to simulate the long-
term impacts in terms of costs and quality-adjust-
ed life years of physical activity interventions for 
adolescents.
 Ź The study incorporates the most recent evidence on 
the effect of increased physical activity in long-term 
chronic disease conditions.
 Ź The model builds on previously published cohort 
models and includes additional health states. In ad-
dition, extensive sensitivity analyses have been per-
formed to relect uncertainty in model structure and 
parameter assumptions.
 Ź A limitation of the present study is that the change 
in activity level over time were estimated using pop-
ulation-level prevalence data due to unavailability of 
longitudinal data describing the lifetime trajectory of 
physical activity and exclusion of long-term impacts 
on other conditions, for example, mental health.
AbStrACt
Objective To develop a model to assess the long-
term costs and health outcomes of physical activity 
interventions targeting adolescents.
Design A Markov cohort simulation model was 
constructed with the intention of being capable of 
estimating long-term costs and health impacts of 
changes in activity levels during adolescence. The model 
parameters were informed by published literature and the 
analysis took a National Health Service perspective over 
a lifetime horizon. Univariate and probabilistic sensitivity 
analyses were undertaken.
Setting School and community.
Participants A hypothetical cohort of adolescents aged 
16 years at baseline.
Interventions Two exemplar school-based: a 
comparatively simple, after-school intervention and a more 
complex multicomponent intervention compared with 
usual care.
Primary and secondary outcome measures Incremental 
cost-effectiveness ratio as measured by cost per quality-
adjusted life year gained.
results The model gave plausible estimates of the 
long-term effect of changes in physical activity. The use 
of two exemplar interventions suggests that the model 
could potentially be used to evaluate a number of different 
physical activity interventions in adolescents. The key 
model driver was the degree to which intervention effects 
were maintained over time.
Conclusions The model developed here has the potential 
to assess long-term value for money of physical activity 
interventions in adolescents. The two applications of 
the model indicate that complex interventions may not 
necessarily be the ones considered the most cost-effective 
when longer-term costs and consequences are taken into 
account.
IntrODuCtIOn
Insufficient physical activity is a key risk factor 
for chronic diseases, such as cardiovascular 
disease, type 2 diabetes, and some types of 
cancer in the general population.1 2 Physical 
activity in young people is associated with 
many health benefits including improved 
cardiovascular and mental health,3 4 academic 
performance5 and bone health.6 While 
physical activity typically declines with age, 
active children are more likely to become 
active adults.7 8 Although the short-term and 
long-term health benefits of physical activity 
are well-documented,9 10 in England, nearly 
half of all young people fail to achieve the 
recommended levels of physical activity, 
based on self-reports.11 12 When measured 
objectively using accelerometers, the prev-
alence of inactivity is higher still (91% boys 
and 98% girls).13
The high prevalence of physical inactivity in 
young people places a significant burden on 
healthcare services and the wider economy. 
A 2014 report estimated a lifetime cost of 
£53.3 billion related to inactivity among 
today’s 11–25 years old,12 taking into consid-
eration the fact that physical activity levels in 
childhood predict adult activity levels.14 This 
estimate includes direct healthcare costs of 
treating the burden of type 2 diabetes, coro-
nary heart disease (CHD), stroke and colon 
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cancer, and the risk of premature death and morbidity 
associated with these illnesses.
In recent years, there has been increasing interest in 
identifying interventions to improve young people’s 
activity levels. Although some school-based physical activity 
interventions show promising effects15 16 the existing 
evidence is very limited in both quantity and quality.17 
While improvements in physical activity may have long-
term health benefits, the evidence on the longer-term 
costs and health benefits of interventions in adolescence 
is particularly sparse. Trials generally do not have suffi-
cient follow-up to capture associated longer-term costs 
and consequences directly.18 Quantifying the economic 
and health benefits associated with physical activity inter-
ventions would help decision makers to make informed 
decisions, that is, assessing whether these interventions 
are an efficient use of limited healthcare resources.
Furthermore, much of the health benefits of physical 
activity interventions occur in the future. Also, many 
interventions are focused on adult or elderly popula-
tions. The long-term costs and health benefits of physical 
activity interventions in an adolescent population are a 
comparatively scarcely researched area. To fill this crit-
ical research gap, we developed a decision analytic model 
aimed at quantifying the potential long-term costs and 
quality-adjusted life-year (QALY) implications of changes 
in activity levels during adolescence. We then illustrate 
some of the practical implications of taking a longer-term 
perspective by applying the model to two exemplar inter-
vention programmes to show how the changes in levels 
of adolescent physical activity could affect activity levels 
throughout lifetime, as well the resulting longer-term 
costs and health benefits.
MethODS
We developed a probabilistic, age-dependant and 
gender-dependant state-transition Markov model to simu-
late a cohort of healthy adolescents. The model estimates 
the risk of cardiovascular, type 2 diabetes and oncological 
events over a lifetime, and associated costs and quality 
of life. The model structure was based on the previously 
published models19 20 that assessed the cost-effectiveness 
of physical activity interventions in the adult popula-
tion. The model combines information from a variety of 
sources relating to disease and physical activity epidemi-
ology, mortality, effectiveness, health-related quality of 
life and costs.
Structuring the model
Model and population type
A simulated cohort of 10 000 healthy adolescents aged 16 
entered the model. The intervention is assumed to have 
been delivered at the start of the first model cycle. At the 
end of the first cycle, based on the intervention effective-
ness evidence, a proportion of cohort members move to 
a higher activity level. Depending on the sustainability 
of the intervention effect, in subsequent years cohort 
members obtain an annual probability of remaining at 
the new activity level or moving to a lower physical activity 
state or to a disease state or death.
Model states
The health states included in the model are ‘healthy’ 
(disease-free), ‘having a chronic disease’ and ‘dead’. 
At the beginning of the simulation, we assumed that all 
cohort members start out as healthy, that is, disease free. 
Within the model, physical activity is classified into four 
activity levels (inactive, low, moderate and high) based 
on weekly moderate-to-vigorous physical activity (MVPA). 
The model has 11 health states in total: four physical 
activity levels, six chronic disease conditions, and a dead 
state (figure 1). Among the healthy, the risk of devel-
oping one of the six diseases depends on age, gender 
and activity level. For simplicity, we assumed that health 
states included in the model were mutually exclusive, and 
cohort members did not move between disease states.
The selection of the disease conditions was based 
on currently available evidence describing the associa-
tion between physical activity and disease risk,21–26 and 
economic and health burden of diseases related to phys-
ical inactivity in the UK.27 Disease conditions are all asso-
ciated with costs and impact on quality of life. For each of 
the selected exemplar interventions, we re-ran the model 
changing appropriate data to reflect the costs and effec-
tiveness of these interventions. Costs and QALYs were 
discounted at 3.5% as recommended for the National 
Institute for Health and Care Excellence (NICE) refer-
ence case.28
Time horizon
The time horizon of the model is 65 years, that is, the 
model follows the cohort of 16 years old until they reach 
81 years—the average life expectancy in the UK.29 A half-
cycle correction was applied under the assumption that 
each transition happened halfway during the cycle.30
Populating the model
Baseline population and activity levels
Data on age and gender distribution of the initial 
population were obtained from the Office for National 
Statistics (ONS).31 An estimate of baseline activity level 
(weekly MVPA) was taken from the 2012 Health Survey 
for England (HSE).32 Participants were divided into four 
levels (<30, 30–149, 150–420 and ≥421 MVPA min per 
week) of activity by age and gender, based on the UK 
Department of Health’s physical activity recommenda-
tions.11 The moderate activity category equates to the 
current recommended level of physical activity.
Transition probabilities
To estimate the annual probability of developing each 
disease, the annual incidence rates for the disease condi-
tions included in the model were taken from popula-
tion-based studies in the UK.33–39 These are probabilities 
for the general adult population and included all four 
activity levels. In order to adjust the differential risk of 
Protected by copyright.
 o
n
 19 August 2019 at The Librarian J B M
orrell Library.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-027566 on 18 August 2019. Downloaded from 
3Gc VS, et al. BMJ Open 2019;9:e027566. doi:10.1136/bmjopen-2018-027566
Open access
Figure 1 Conceptual overview of the model. CHD, coronary heart disease.
developing these disease conditions by activity level, we 
first derived the probability of developing that disease 
among inactive people, using the method presented by 
Hurley et al.40 The probabilities for each condition among 
low, moderate and high activity levels in the cohort were 
estimated by multiplying the probabilities for the inac-
tive population by corresponding relative risks for low, 
moderate and high activity.21–24 26 Online supplementary 
section A table S1 provides the transitional parameters.
Mortality rates
All-cause mortality rates by age and gender were derived 
from the ONS.29 Mortality consists of disease-specific 
mortality and mortality due to other causes. We estimated 
other-cause mortality by subtracting the total number of 
deaths due to the six disease conditions included in the 
model from the all-cause mortality total. The other-cause 
mortality rates by age and gender were assumed constant 
in the sensitivity analysis. The model assumes that a given 
proportion of CHD, stroke and heart failure (HF) events 
would be immediately fatal and people who survived one 
of these events had an increased subsequent risk of death 
(online supplementary section A table S2). Case fatality 
rates for these health states were taken from published 
population-based studies in the UK.41–43
Individuals with type 2 diabetes were assigned an 
increased risk of mortality using data from a published 
meta-analysis.44 Based on standardised mortality ratios 
reported in long-term follow-up studies of first-ever 
patients’ stroke, a twofold increase in the risk of death 
after 1 year45 was applied to the general mortality rates 
from the life tables to reflect the higher mortality burden 
postvascular event. Annual mortality rates following the 
first HF event were estimated from 10-year case fatality 
rates in patients admitted with a principal diagnosis of HF 
in Scotland.43 The age-adjusted 5-year net survival rates 
from the ONS46 were used to estimate an annual risk of 
cancer death. It was assumed that the mortality rates do 
not increase due to cancer beyond 5 years after a cancer 
diagnosis.
Interventions
We reviewed the literature to identify physical activity 
interventions targeting the adolescent population. For 
primarily illustrative purposes, we selected two inter-
ventions to test the model and explore the health and 
economic impact of smaller and greater changes in 
physical activity. The first was a simple after-school inter-
vention, not costly but likely with smaller benefits,47 the 
second a more complex, multicomponent interven-
tion—more costly intervention but with higher expected 
benefits.15
After school intervention programme
Mears and Jago47 included six after-school interventions 
in their meta-analysis and reported the pooled mean 
difference of 4.84 (−0.94 to 10.61) min of MVPA per 
day. These programmes typically included structured 
or unstructured play, planned MVPA, single or multis-
port physical activity programme or adhering to specific 
instructions (eg, maintaining sufficient intensity of exer-
cise during a session).
Multicomponent intervention
The intervention effect for school-based multicompo-
nent intervention was taken from a cluster-randomised 
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Table 1 Health state utilities and costs used in the model
Parameter Value SE Distribution Source
Health state utilities 54
  CHD 0.65 0.0203 Beta (α=357, β=191)
  Stroke 0.52 0.0192 Beta (α=355, β=323)
  Heart failure 0.49 0.0194 Beta (α=326, β=335)
  Type 2 diabetes 0.66 0.0054 Beta (α=5032, β=2548)
  Breast cancer 0.76 0.0133 Beta (α=791, β=256)
  Colorectal cancer 0.67 0.0314 Beta (α=150, β=73)
Costs of health states
  CHD irst event £5562 £556 Gamma (α=100, β=56) 48
  CHD subsequent £214 £21 Gamma (α=100, β=2) 48
  CHD fatal £1458 £146 Gamma (α=100, β=15) 48
  Stroke irst event £10 062 £1006 Gamma (α=100, β=101) 48
  Stroke subsequent £2705 £270 Gamma (α=100, β=27) 48
  Stroke fatal £8805 £881 Gamma (α=100, β=88) 48
  HF £2402 £240 Gamma (α=100, β=24) 49
  HF subsequent £815 £82 Gamma (α=100, β=8) 49
  Type 2 diabetes £1257 £126 Gamma (α=100, β=13) 50
  Breast cancer £12 155 £1215 Gamma (α=100, β=122) 51
  Colorectal cancer £16 978 £1698 Gamma (α=100, β=170) 52
CHD, coronary heart disease; HF, heart failure.
trial15 implemented in secondary schools in Australia. 
The intervention included multiple intervention strat-
egies (eg, active physical education lessons, enhanced 
school sport, supportive school physical activity policies) 
targeting physical activity. The reported difference in min 
of MVPA per day between the intervention and control 
arm at follow-up was 7.0 (2.7–11.4).
Costs, currency, price date and conversion
The annual costs incurred in each disease health state 
were based on previously published studies (table 1). First-
year costs and subsequent year costs are assigned for each 
of the health states modelled. Costs of CHD and stroke 
were taken from the statins health technology assess-
ment.48 Costs for HF were taken from the UK Prospective 
Diabetes Study (UKPDS).49 Costs for type 2 diabetes were 
based on Diabetes Glycaemic Education and Monitoring 
trial and included medication and other healthcare 
costs.50 Cost for breast cancer was taken from a screening 
appraisal for breast cancer.51 The estimated cost is the 
weighted average treatment costs depending on the prog-
nosis at diagnosis. Cost for colorectal cancer was based 
on a screening appraisal.52 The appraisal reported the 
lifetime cost of colorectal cancer according to the cancer 
stage, and a weighted average cost was estimated using 
the proportion of cancers identified at each stage. All the 
costs were inflated to 2013–2014.53
Health state utility values
Utility weights were used to value a year spent in each of 
the health states used in the model. A value of 1 means 
that the health state would be equivalent to full health 
and 1 year in that state would generate 1 QALY. For 
example, if an individual spent ten years in the CHD state 
with a utility of 0.65, they would accrue 6.5 QALYs. The 
same number of QALYs could be generated by spending 
6.5 years in a health state of 1. The lower the utility value, 
the worse the health state is considered to be. The weights 
used to value disease health states are given in table 1 
and were taken from Sullivan et al,54 who used UK based 
community preferences to derive EQ-5D scores from the 
Medical Expenditure Panel Survey. Utility weights for 
activity level by age and gender were extracted from the 
HSE 2012 (table 2).55
Modelling health beneits
We estimated the probability of moving to a higher activity 
level after intervention by adding intervention-specific 
MVPA minutes to baseline levels. We then calculated the 
proportion of cohort members that moved from one 
activity level to another, and we used this proportion 
as a transition probability. Members of the cohort who 
improved physical activity level at the end of cycle 0 were 
assumed to have a lower probability of developing type 2 
diabetes, CHD, stroke, HF or any of the cancers.
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Table 2 Baseline utilities associated with physical activity level
Age-group
Utility values by activity level
Distribution SourceInactive Low Moderate High
16–34 0.897 0.918 0.937 0.943 Beta 55
35–44 0.770 0.889 0.914 0.927 Beta 55
45–54 0.696 0.852 0.899 0.921 Beta 55
55–64 0.648 0.861 0.863 0.907 Beta 55
65–74 0.657 0.823 0.870 0.897 Beta 55
65–74 0.701 0.829 0.850 0.876 Beta 55
Inactive: <30; Low: 30–149; Moderate: 150–420 and High: ≥421 MVPA min per week.
MVPA, moderate-to-vigorous physical activity.
Estimation of the sustainability of intervention effect
The decline in activity levels over time in the ‘no inter-
vention’-group was modelled based on data from a recent 
meta-analysis examining the change in activity level from 
adolescence to adulthood8 as well as using prevalence data 
from the 2012 HSE. The meta-analysis showed a decrease 
of 6.5 min/day of MVPA in boys and 5.5 min/day of MVPA 
in girls from adolescence to adulthood. As the review 
included studies reporting at least one measurement 
between both 13–19 years and 16–30 years, we assumed 
that the decrease in MVPA minutes was for a 7-year period. 
For the intervention group, a 50% decline in intervention 
effect per year postintervention was assumed. Therefore, 
the activity levels decreased towards the control activity 
level after 7 years. The effect of this was that a number of 
individuals in the intervention group were re-categorised 
into higher activity groups immediately after the interven-
tion. Over time, many of these individuals would fall back 
into lower activity groups, and at the end of 7th year, there 
was no real difference between intervention and control 
groups. To account for the decline in physical activity 
occurring with age across the life course, we estimated 
age-related activity levels using 2012 HSE data on physical 
activity prevalence by age and gender. Activity levels were 
estimated in three broad age groups: 24–44, 45–64 and 
≥65 years to reflect activity-level differences in adulthood, 
middle-age and retirement.
Estimation of costs of intervention
Costs of delivering after-school intervention were taken 
from a cluster randomised feasibility study in the UK.56 
The authors reported cost estimates (£49 per participant, 
2012–2013 price) of a teaching assistant led extra-curric-
ular physical activity intervention. We took that as an indic-
ative cost of the after-school intervention, inflated to 2014 
prices (£51 per participant). The cost includes intervention 
delivery costs, one-off training and non-recurrent costs such 
as consultation and intervention development work.
Sutherland et al performed an economic evaluation 
alongside the multicomponent intervention57 and reported 
that the intervention costed $A394 per participant. This 
cost includes opportunity costs for delivery of strategies 
by school staff and community sport and fitness providers, 
materials and printing. We converted this cost to 2014-
pound sterling (£190 per participant) by applying the gross 
domestic product deflator index and purchasing power 
parities conversion rates using the CCEMG-EPPI-Centre 
Cost Converter (V.1.5).58 We added the intervention cost in 
the first year for the intervention groups.
Validation
The model structure, data sources and the effectiveness 
evidence used in the exemplar interventions and model 
results were validated by the study team comprising health 
economists, behavioural epidemiologists and trialists. 
Internal validity of the model code was ensured using 
several tests and by assuming a constant total population 
throughout the calculations. Furthermore, model predic-
tions were examined to make sure that results from the 
model were consistent with the model’s specifications. We 
specifically checked lifetime incidence and mortality, as well 
as physical activity prevalence by age and gender. Details can 
be found in online supplementary section B figures S1–10.
Cost-effectiveness analysis
We used NICE reference case28 and followed existing 
guidelines for modelling.59 The analysis was performed 
from the perspective of the NHS and personal social 
services. Costs and health outcomes were discounted at 
3.5% per year.28 We estimated the cost-effectiveness ratio 
for each intervention compared with ‘no intervention’. 
The incremental costs and QALYs gained by the inter-
vention were estimated and averaged across the simu-
lated cohort. The incremental cost-effectiveness ratio 
(ICER) was estimated as a ratio between the additional 
expected cost of the intervention, and the additional 
expected QALYs gained, both relative to the ‘no inter-
vention’ alternative. The intervention was considered 
cost-effective if the ICER was no more than the lower 
NICE recommended threshold of £20 000 per QALY. 
The uncertainty surrounding the estimates of cost-effec-
tiveness is presented using cost-effectiveness acceptability 
curves (CEACs). A CEAC shows the probability that an 
intervention is cost-effective compared with alternative 
intervention for a range of cost-effectiveness thresholds.60
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Table 3 Incremental cost-effectiveness ratios in the base-case and sensitivity analyses
Total cost (£) Total QALYs
Incremental 
cost (£)
Incremental 
QALY ICER
Base-case analysis
  No intervention 4441 21.705 – – –
  After-school intervention 4491 21.710 50.64 0.004 11 486
  Multicomponent intervention 4629 21.712 137.89 0.002 68 056
No (0%) decay of intervention effects
  No intervention 4437 21.707 – – –
  After-school intervention 4451 21.898 14.32 0.191 75
  Multicomponent intervention 4571 21.987 119.59 0.089 1342
33% decay of intervention effects
  No intervention 4430 21.705 – – –
  After-school intervention 4479 21.718 48.86 0.013 3661
  Multicomponent intervention 4616 21.726 136.94 0.008 17 661
100% decay of intervention effects
  No intervention 4432 21.705 – – –
  After-school intervention 4484 21.707 51.42 0.002 28 838
  Multicomponent intervention 4621 21.708 137.61 0.001 189 897
Time horizon (10 years)
  No intervention 41 7.167 – – –
  After-school intervention 92 7.170 51.47 0.004 14 204
  Multicomponent intervention 231 7.172 138.60 0.002 75 100
Time horizon (20 years)
  No intervention 219 12.835 – – –
  After-school intervention 270 12.838 51.09 0.004 13 414
  Multicomponent intervention 408 12.840 138.19 0.002 72 346
ICER, incremental cost-effectiveness ratio (incremental cost/incremental QALY); QALY, quality-adjusted life year.
Sensitivity analyses
We performed sensitivity analyses by changing interven-
tion decay rates and time horizon that affect cost-effective-
ness results. Deterministic one-way, scenario and extreme 
value analyses were undertaken. This was complemented 
by probabilistic sensitivity analysis (PSA) to assess the 
combined effects of uncertainty in the input parameters 
by simultaneously sampling input parameter values from 
within a specified distribution using Monte Carlo simu-
lations (2000 iterations). Uncertainty about the sustain-
ability of the intervention effects was assessed by varying 
the decay rates between 0% and 100%. In our base-case 
analysis, we assumed that the intervention effects are 
sustained for the first year but decay exponentially at a 
rate of 50% per annum thereafter, resulting in virtually 
no intervention effect after 7 years.
Probabilities of disease events and utilities were assumed 
to follow a beta distribution; costs followed a gamma distri-
bution and risk reductions/HRs a lognormal distribution.61 
The model was developed and implemented in Microsoft 
Excel.
Patient and public involvement
Public involvement informed the questions addressed 
in the overarching research project of which this study 
is a part. No further public involvement was sought with 
regards to the development of the research question, the 
outcome measures or the study design.
reSultS
base-case analysis
In our base-case analysis, both after-school and multicom-
ponent interventions were associated with higher costs and 
were more effective than no intervention (table 3). The 
multicomponent intervention was associated with a QALY 
gain of 0.002 at an incremental cost of £138, compared with 
the after-school intervention, yielding an ICER of £68 056.
Sensitivity analyses
Sensitivity analyses were implemented, varying the base-
case assumptions and inputs, as outlined in the methods 
section (table 3). Both the after-school and multicompo-
nent interventions had more favourable ICERs at lower 
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Figure 2 Scatter plot of incremental costs and QALYs for each intervention, relative to no intervention. QALY, quality-adjusted 
life-year.
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Figure 3 Cost-effectiveness acceptability curves. QALY, quality-adjusted life-year.
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decay rates, indicating that cost-effectiveness of physical 
activity interventions depends on the sustainability of 
intervention effects over time. The results of PSA are 
presented on the cost-effectiveness plane (figure 2), with 
simulations found to lie predominantly in the northeast 
quadrant indicating—as expected—an improved health 
outcome but also at higher spending on physical activity 
interventions.
Figure 3 depicts the probability of the interventions 
being cost-effective. At a threshold value of £20 000 
per QALY gained, the after-school intervention has the 
highest probability of being cost-effective (59%) while 
for the multicomponent intervention this probability is 
at 8%.
DISCuSSIOn
Main indings
We found that modelling the long-term effects of phys-
ical activity among adolescents is feasible, and the model 
developed here has the potential to estimate the long-
term cost-effectiveness of such interventions. The appli-
cation of the model on two exemplar physical activity 
interventions in adolescents—one a simple, brief inter-
vention and the other a more complex resource-intensive 
one—revealed only small differences in terms of lifetime 
costs per QALYs between the two. Hence, more complex 
and resource-intensive interventions need not necessarily 
be better value-for-money in the longer-term compared 
with cheaper, more targeted approaches. Our findings 
underline that modelled cost-effectiveness estimates are 
critically sensitive to assumptions around the sustain-
ability of intervention effects.
Comparison with previous models
Two previous UK-based modelling studies evaluating the 
cost-effectiveness of community based physical activity 
interventions included young people. Although Frew et 
al
20 used the same basic modelling approach, their model 
included only three activity categories and study partici-
pants included both young people and adults (16–70 years 
old). By contrast, our model has four physical activity 
categories, included two more health states and health 
effects are modelled over a lifetime (with a time horizon 
of 65 years). Pringle et al62 evaluated seven broad catego-
ries of community based physical activity interventions 
(one of which was related to the interventions consid-
ered here). Their analysis was based on NICE/Matrix 
model63 which used two activity categories (active or 
inactive) with four disease states. However, they did not 
focus on young people. Recently, Lee and colleagues64 
modelled the economic and health impact of increasing 
children’s physical activity in the USA. However, unlike in 
the current model, their model specifically looked at the 
influence of physical activity on weight status and meta-
bolic profiles and ignored decay in intervention effects or 
the naturally occurring decline in physical activity associ-
ated with ageing.
Strengths and limitations
Although our model used a similar modelling framework 
as previous models,19 20 we included additional health 
states and focused on adolescent physical activity inter-
ventions—this approach has hitherto been neglected, 
despite the potential importance of intervening at this 
key stage. We also include the most up to date available 
evidence on disease conditions. UK-specific incidence 
rates were used to ensure that patients entering the 
model match the likely distribution of events in the UK. 
We chose not to include sedentary behaviour, as there is 
ongoing debate around its impact on health independent 
of physical activity.65
As with all models, assumptions were required for the 
analysis. The model presented here is a simplification of 
a very complex problem. The baseline age of the cohort 
is 16 years and the effect of physical activity interven-
tions are likely to differ depending on the population 
age at baseline. We included six disease conditions that 
have established links with physical (in)activity. This 
might underestimate the potential impact of physical 
activity on other disease conditions, most notably mental 
health. The effect of physical activity on the prevention 
of depression is still a subject of debate,66 and a clear 
dose–response relationship between physical activity and 
reduced depression is not readily apparent.67 Further 
empirical evidence is required to facilitate its inclusion 
in a future iteration of the model. The current model 
does not allow for transitions between disease states as 
this requires more complex modelling. However, this 
may underestimate the potential impact of physical 
activity. For example, participants with type 2 diabetes 
tend to have a higher risk of developing cardiovascular 
conditions.68 Although the intervention was aimed at 
adolescents, due to the nature of the disease conditions 
included in the model, it would mainly be older adults 
who develop these diseases.
Our assumption on the decay rates of the additional 
effect of the intervention, which was based on previous 
modelling studies,19 69 70 would mean that there would be 
very little difference in activity between groups at time 
points when individuals are starting to develop these 
diseases. We tested different assumptions on the main-
tenance of intervention effect to examine influence in 
cost-effectiveness results. Further research into main-
tenance of intervention effect would provide valuable 
information. Our analysis focused on physical activity 
and only considered direct effects that might result from 
changes in this health behaviour, while holding any other 
health behaviours constant. In the real world, physical 
activity would be expected to interact with other health 
behaviour choices, in ways that might well affect longer 
term cost and health outcomes. The existing, very sparse, 
literature on the interaction between different health 
behaviours suggest a complex and likely context-specific 
picture.64 71
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COnCluSIOn
Interventions to promote physical activity among adoles-
cents represent a potentially promising public health 
measure to reduce the burden of cardiovascular and 
other non-communicable diseases. Faced with limited 
resources, governments need to carefully weigh the costs 
of any proposed interventions against the associated 
health benefits expected to be realised over the longer 
term, in order to ensure that net health gains are maxi-
mised. The model developed here has the potential to 
assess the long-term, beyond trial duration, value-for-
money of such interventions. The two purely illustra-
tive applications of the model convey the notion that 
complex, resource intensive interventions may not neces-
sarily be the ones considered the better buys compared 
with cheaper, more targeted ones. Maintaining the effect 
of any behaviour change interventions is challenging as 
they require personal commitment, encouragement and 
support over time.
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